Dr John Pavlov, MD | |
2819 Denny Ave, Pascagoula, MS 39581-5301 | |
(228) 762-3466 | |
(228) 762-6349 |
Full Name | Dr John Pavlov |
---|---|
Gender | Male |
Speciality | General Practice |
Experience | 37 Years |
Location | 2819 Denny Ave, Pascagoula, Mississippi |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1124179791 | NPI | - | NPPES |
00012527 | Medicaid | MS | |
080186277 | Other | MEDICARE RAILROAD | |
646000515 | Other | TRICARE | |
646000515 | Other | BLUE CROSS OF MS | |
009928105 | Medicaid | AL |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207P00000X | Emergency Medicine | MS11764 (Mississippi) | Secondary |
207Q00000X | Family Medicine | 11764 (Mississippi) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Singing River Health System | Pascagoula, MS | Hospital |
Garden Park Medical Center | Gulfport, MS | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Singing River Health System | 3870405194 | 156 |
News Archive
With substance abuse now accounting for one in 14 hospital admissions and generating billions in health care costs, leading scientists held a briefing on Capitol Hill today to present the evidence that we already have and the evidence we need in treating and preventing the use and abuse of alcohol, drugs and tobacco.
Higher levels of melatonin, a hormone involved in the sleep-wake cycle, may suggest decreased risk for developing advanced prostate cancer, according to results presented here at the AACR-Prostate Cancer Foundation Conference on Advances in Prostate Cancer Research, held Jan. 18-21.
Acucela Inc., a clinical-stage biotechnology company focused on developing new treatments for blinding eye diseases, and Otsuka Pharmaceutical Co., Ltd., today announced that they have received Fast Track designation from the U.S. Food and Drug Administration (FDA) for ACU-4429, an investigational oral treatment for dry age-related macular degeneration (dry AMD).
Research from life-saving charity Air Ambulance Kent Surrey Sussex (KSS) in partnership with the University of Surrey has shown the benefits of dispatching HEMS to patients with a sudden, unexplained LOC of medical origin and a high prevalence of acute neurological pathology.
MAXIMUS, a leading provider of government services worldwide, today reported financial results for its first quarter ended December 31, 2013.
› Verified 4 days ago
Entity Name | Singing River Health System |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1083893937 PECOS PAC ID: 3870405194 Enrollment ID: O20031104000435 |
News Archive
With substance abuse now accounting for one in 14 hospital admissions and generating billions in health care costs, leading scientists held a briefing on Capitol Hill today to present the evidence that we already have and the evidence we need in treating and preventing the use and abuse of alcohol, drugs and tobacco.
Higher levels of melatonin, a hormone involved in the sleep-wake cycle, may suggest decreased risk for developing advanced prostate cancer, according to results presented here at the AACR-Prostate Cancer Foundation Conference on Advances in Prostate Cancer Research, held Jan. 18-21.
Acucela Inc., a clinical-stage biotechnology company focused on developing new treatments for blinding eye diseases, and Otsuka Pharmaceutical Co., Ltd., today announced that they have received Fast Track designation from the U.S. Food and Drug Administration (FDA) for ACU-4429, an investigational oral treatment for dry age-related macular degeneration (dry AMD).
Research from life-saving charity Air Ambulance Kent Surrey Sussex (KSS) in partnership with the University of Surrey has shown the benefits of dispatching HEMS to patients with a sudden, unexplained LOC of medical origin and a high prevalence of acute neurological pathology.
MAXIMUS, a leading provider of government services worldwide, today reported financial results for its first quarter ended December 31, 2013.
› Verified 4 days ago
Entity Name | Emergency Room Group Ltd |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1093112039 PECOS PAC ID: 6608190798 Enrollment ID: O20150120002157 |
News Archive
With substance abuse now accounting for one in 14 hospital admissions and generating billions in health care costs, leading scientists held a briefing on Capitol Hill today to present the evidence that we already have and the evidence we need in treating and preventing the use and abuse of alcohol, drugs and tobacco.
Higher levels of melatonin, a hormone involved in the sleep-wake cycle, may suggest decreased risk for developing advanced prostate cancer, according to results presented here at the AACR-Prostate Cancer Foundation Conference on Advances in Prostate Cancer Research, held Jan. 18-21.
Acucela Inc., a clinical-stage biotechnology company focused on developing new treatments for blinding eye diseases, and Otsuka Pharmaceutical Co., Ltd., today announced that they have received Fast Track designation from the U.S. Food and Drug Administration (FDA) for ACU-4429, an investigational oral treatment for dry age-related macular degeneration (dry AMD).
Research from life-saving charity Air Ambulance Kent Surrey Sussex (KSS) in partnership with the University of Surrey has shown the benefits of dispatching HEMS to patients with a sudden, unexplained LOC of medical origin and a high prevalence of acute neurological pathology.
MAXIMUS, a leading provider of government services worldwide, today reported financial results for its first quarter ended December 31, 2013.
› Verified 4 days ago
Entity Name | Singing River Gulfport |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1861010159 PECOS PAC ID: 5294154829 Enrollment ID: O20201001001497 |
News Archive
With substance abuse now accounting for one in 14 hospital admissions and generating billions in health care costs, leading scientists held a briefing on Capitol Hill today to present the evidence that we already have and the evidence we need in treating and preventing the use and abuse of alcohol, drugs and tobacco.
Higher levels of melatonin, a hormone involved in the sleep-wake cycle, may suggest decreased risk for developing advanced prostate cancer, according to results presented here at the AACR-Prostate Cancer Foundation Conference on Advances in Prostate Cancer Research, held Jan. 18-21.
Acucela Inc., a clinical-stage biotechnology company focused on developing new treatments for blinding eye diseases, and Otsuka Pharmaceutical Co., Ltd., today announced that they have received Fast Track designation from the U.S. Food and Drug Administration (FDA) for ACU-4429, an investigational oral treatment for dry age-related macular degeneration (dry AMD).
Research from life-saving charity Air Ambulance Kent Surrey Sussex (KSS) in partnership with the University of Surrey has shown the benefits of dispatching HEMS to patients with a sudden, unexplained LOC of medical origin and a high prevalence of acute neurological pathology.
MAXIMUS, a leading provider of government services worldwide, today reported financial results for its first quarter ended December 31, 2013.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Dr John Pavlov, MD 2101 Highway 90, Gautier, MS 39553-5340 Ph: () - | Dr John Pavlov, MD 2819 Denny Ave, Pascagoula, MS 39581-5301 Ph: (228) 762-3466 |
News Archive
With substance abuse now accounting for one in 14 hospital admissions and generating billions in health care costs, leading scientists held a briefing on Capitol Hill today to present the evidence that we already have and the evidence we need in treating and preventing the use and abuse of alcohol, drugs and tobacco.
Higher levels of melatonin, a hormone involved in the sleep-wake cycle, may suggest decreased risk for developing advanced prostate cancer, according to results presented here at the AACR-Prostate Cancer Foundation Conference on Advances in Prostate Cancer Research, held Jan. 18-21.
Acucela Inc., a clinical-stage biotechnology company focused on developing new treatments for blinding eye diseases, and Otsuka Pharmaceutical Co., Ltd., today announced that they have received Fast Track designation from the U.S. Food and Drug Administration (FDA) for ACU-4429, an investigational oral treatment for dry age-related macular degeneration (dry AMD).
Research from life-saving charity Air Ambulance Kent Surrey Sussex (KSS) in partnership with the University of Surrey has shown the benefits of dispatching HEMS to patients with a sudden, unexplained LOC of medical origin and a high prevalence of acute neurological pathology.
MAXIMUS, a leading provider of government services worldwide, today reported financial results for its first quarter ended December 31, 2013.
› Verified 4 days ago
Dr. Kevin Scott Cooper, MD,MPH Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4305 Denny Ave, Pascagoula, MS 39581 Phone: 228-762-2044 Fax: 228-762-2064 | |
Matthew Bosarge, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2819 Denny Ave, Pascagoula, MS 39581 Phone: 228-762-3466 Fax: 228-762-6349 | |
Dr. Sheila Dillard, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2809 Denny Ave, Pascagoula, MS 39581 Phone: 228-588-2938 | |
Dr. Gary H. Groff, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2819 Denny Ave., Pascagoula, MS 39581 Phone: 228-762-3466 Fax: 228-762-6349 | |
Dr. Martin Bydalek, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 2819 Denny Ave, Pascagoula, MS 39581 Phone: 228-762-3466 | |
Dr. Teresa A Williamson, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2819 Denny Ave., Pascagoula, MS 39581 Phone: 228-762-3466 Fax: 228-762-6349 | |
Dr. Vernon W Doster, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 3616 Hospital Street, Suite D, Pascagoula, MS 39581 Phone: 228-762-8187 Fax: 228-762-6934 |